Hæmofili kliniske forsøg i Indiana
9 studier for Hæmofili søger deltagere på steder i Indiana.
Byer i Indiana
Officiel studietekst (engelsk)
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- Innovative Hematology, Inc., Indianapolis
RekruttererFase 3
Alder 18 og opefter · Mænd · Opdateret 2. okt. 2026 · NCT05568719A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
- Indiana Hemophilia-Thromb Ctr, Indianapolis
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 64 · Mænd · Opdateret 18. sep. 2026 · NCT07220564A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
- Indiana Hemophilia & Thrombosis center, Indianapolis
RekruttererFase 1/2
Alder 2 til 59 · Mænd · Opdateret 11. sep. 2026 · NCT05987449A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- Innovative Hematology, Inc., Indianapolis
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT07416604ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Indiana Hemophilia and Thrombosis Center, Indianapolis
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 17. aug. 2026 · NCT04398628Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
- Indiana Hemophilia & Thrombosis Center, Indianapolis
RekruttererObservationsstudie
Alder 6 til 19 · Alle køn · Opdateret 2. jul. 2026 · NCT05022459Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
- Innovative Hematology, Inc. (IHI), Indianapolis
RekruttererFase 1
Alder 0 til 90 · Alle køn · Opdateret 3. apr. 2026 · NCT05500807Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy
- Innovative Hematology, Inc.- Site Number : 8400006, Indianapolis
RekruttererFase 4
Alder 12 og opefter · Alle køn · Opdateret 18. nov. 2025 · NCT06941870Hemlibra in Mild Hemophilia A
- Indiana Hemophila @Thrombosis Center, Indianapolis
RekruttererFase 4
Alder 5 til 45 · Mænd · Opdateret 15. mar. 2024 · NCT04567511Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.